English
Insider transactions
EDGARSCIENTIFIC INDUSTRIES, INC.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-18.
- Open-market purchases (code P)
- 11 transactions, 140,200 shares
- Sum of shares × price per share: 88,419.54
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–20 of 20
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-05 Filed 2026-11-05 | MOORE JOHN A Director · Officer: Chairman of the Board | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 10,000 | 0.6 | 6,000Derived: shares × price per share. Exact value 6000.0. | 1,018,941 | Direct (D) | No | — | Open filing 0001182944-26-000009 Read from the filing’s XML Dispute this row |
| 2026-10-31 Filed 2026-11-05 | MOORE JOHN A Director · Officer: Chairman of the Board | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 7,100 | 0.6 | 4,260Derived: shares × price per share. Exact value 4260.0. | 1,008,941 | Direct (D) | No | — | Open filing 0001182944-26-000008 Read from the filing’s XML Dispute this row |
| 2026-10-31 Filed 2026-11-05 | MOORE JOHN A Director · Officer: Chairman of the Board | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 51,200 | 0.65 | 33,280Derived: shares × price per share. Exact value 33280.00. | 1,001,841 | Direct (D) | No | — | Open filing 0001182944-26-000007 Read from the filing’s XML Dispute this row |
| 2026-08-20 Filed 2026-09-08 | MOORE JOHN A Director · Officer: Chairman of the Board | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 5,000 | 0.76 | 3,800Derived: shares × price per share. Exact value 3800.00. | 950,641 | Direct (D) | No | — | Open filing 0001182944-26-000006 Read from the filing’s XML Dispute this row |
| 2026-08-20 Filed 2026-08-20 | MOORE JOHN A Director · Officer: Chairman of the Board | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 14,700 | 0.7112 | 10,454.64Derived: shares × price per share. Exact value 10454.6400. | 945,641 | Direct (D) | No | — | Open filing 0001182944-26-000005 Read from the filing’s XML Dispute this row |
| 2026-06-02 Filed 2026-06-18 | MOORE JOHN A Director · Officer: Chairman of the Board | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 4,000 | 0.7113 | 2,845.2Derived: shares × price per share. Exact value 2845.2000. | 930,871 | Direct (D) | No | — | Open filing 0001182944-26-000004 Read from the filing’s XML Dispute this row |
| 2026-03-23 Filed 2026-03-24 | MOORE JOHN A Director · Officer: Chairman | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 9,000 | 0.58 | 5,220Derived: shares × price per share. Exact value 5220.00. | 926,871 | Direct (D) | No | — | Open filing 0001182944-26-000003 Read from the filing’s XML Dispute this row |
| 2026-02-19 Filed 2026-03-17 | MOORE JOHN A Director · Officer: Chairman of the Board | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 1,000 | 0.65 | 650Derived: shares × price per share. Exact value 650.00. | 917,871 | Direct (D) | No | — | Open filing 0001182944-26-000002 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-04-01 | SANTOS HELENA R Director · Officer: President and CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | — | — | 433,388 | Direct (D) | No | F1
| Open filing 0001286205-26-000003 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-04-01 | SANTOS HELENA R Director · Officer: President and CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 130,000 | 0 | — | 563,388 | Direct (D) | No | F1
| Open filing 0001286205-26-000004 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-03-17 | MOORE JOHN A Director · Officer: Chairman of the Board | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 230,000 | 0 | — | 886,871 | Direct (D) | No | F1
| Open filing 0001182944-26-000001 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-03-17 | MOORE JOHN A Director · Officer: Chairman of the Board | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 30,000 | 0 | — | 916,871 | Direct (D) | No | — | Open filing 0001182944-26-000001 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-03-17 | BLECHMAN MICHAEL Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 24,000 | 0 | — | 96,186 | Direct (D) | No | F1
| Open filing 0002021300-26-000001 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-03-17 | BLECHMAN MICHAEL Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 20,000 | 0 | — | 116,186 | Direct (D) | No | — | Open filing 0002021300-26-000001 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-03-17 | Rovinsky Zachary Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 45,000 | Direct (D) | No | F1
| Open filing 0002092274-26-000003 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-03-17 | NICOLS JOHN J Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 120,000 | 0 | — | 255,778 | Direct (D) | No | F1
| Open filing 0001238884-26-000001 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-03-17 | NICOLS JOHN J Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 20,000 | 0 | — | 275,778 | Direct (D) | No | F1
| Open filing 0001238884-26-000001 Read from the filing’s XML Dispute this row |
| 2025-12-17 Filed 2025-12-18 | MOORE JOHN A Director · Officer: Chairman | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 6,500 | 0.5315 | 3,454.75Derived: shares × price per share. Exact value 3454.7500. | 663,371 | Direct (D) | No | — | Open filing 0001182944-25-000009 Read from the filing’s XML Dispute this row |
| 2025-12-17 Filed 2025-12-18 | MOORE JOHN A Director · Officer: Chairman | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 11,700 | 0.5435 | 6,358.95Derived: shares × price per share. Exact value 6358.9500. | 656,871 | Direct (D) | No | — | Open filing 0001182944-25-000008 Read from the filing’s XML Dispute this row |
| 2025-12-05 Filed 2025-12-15 | MOORE JOHN A Director · Officer: Chairman | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 20,000 | 0.6048 | 12,096Derived: shares × price per share. Exact value 12096.0000. | 645,171 | Direct (D) | No | — | Open filing 0001182944-25-000007 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| LYTTON LAURENCE W Common Stock | 9.99 | 1,226,104.00 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 5 | Open filing 0000935836-26-000394 Dispute this row |
| Lytton-Kambara Foundation Common Stock | 9.9 | 1,245,527.00 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 5 | Open filing 0000935836-26-000394 Dispute this row |
| Bleichroeder LP Common Stock, $0.05 par value | 21.19 | 2,715,026 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13D/AAmendment 4 | Open filing 0001420506-25-003305 Dispute this row |
| Bleichroeder Holdings LLC Common Stock, $0.05 par value | 21.19 | 2,715,026 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13D/AAmendment 4 | Open filing 0001420506-25-003305 Dispute this row |
| Andrew Gundlach Common Stock, $0.05 par value | 21.19 | 2,715,026 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13D/AAmendment 4 | Open filing 0001420506-25-003305 Dispute this row |
| North Run Capital, LP Common Stock, par value $0.05 per share | 9.99 | 1,189,632 | 09/30/2025 Filed 2025-11-13 | SCHEDULE 13G/AAmendment 4 | Open filing 0001193125-25-279174 Dispute this row |
| North Run Advisors, LLC Common Stock, par value $0.05 per share | 9.99 | 1,189,632 | 09/30/2025 Filed 2025-11-13 | SCHEDULE 13G/AAmendment 4 | Open filing 0001193125-25-279174 Dispute this row |
| Todd B. Hammer Common Stock, par value $0.05 per share | 9.99 | 1,189,632 | 09/30/2025 Filed 2025-11-13 | SCHEDULE 13G/AAmendment 4 | Open filing 0001193125-25-279174 Dispute this row |
| Thomas B. Ellis Common Stock, par value $0.05 per share | 9.99 | 1,189,632 | 09/30/2025 Filed 2025-11-13 | SCHEDULE 13G/AAmendment 4 | Open filing 0001193125-25-279174 Dispute this row |
| Michael Bosco Common Stock, par value $0.05 per share | 9.99 | 1,189,632 | 09/30/2025 Filed 2025-11-13 | SCHEDULE 13G/AAmendment 4 | Open filing 0001193125-25-279174 Dispute this row |
| North Run - Due North Partners, LP Common Stock, par value $0.05 per share | 9.99 | 1,189,632 | 09/30/2025 Filed 2025-11-13 | SCHEDULE 13G/AAmendment 4 | Open filing 0001193125-25-279174 Dispute this row |
| North Run GP, LP Common Stock, par value $0.05 per share | 9.99 | 1,189,632 | 09/30/2025 Filed 2025-11-13 | SCHEDULE 13G/AAmendment 4 | Open filing 0001193125-25-279174 Dispute this row |
| Brian L. Pessin Common stock, par value $0.05 per share | 3.3 | 397,531 | 08/21/2025 Filed 2025-08-22 | SCHEDULE 13D/AAmendment 3 | Open filing 0001140361-25-032306 Dispute this row |
| Norman H. Pessin Common stock, par value $0.05 per share | 4.7 | 570,000 | 08/21/2025 Filed 2025-08-22 | SCHEDULE 13D/AAmendment 3 | Open filing 0001140361-25-032306 Dispute this row |
| PESSIN SANDRA F Common stock, par value $0.05 per share | 3.9 | 466,507 | 08/21/2025 Filed 2025-08-22 | SCHEDULE 13D/AAmendment 3 | Open filing 0001140361-25-032306 Dispute this row |
| North Run Capital, LP Common Stock, par value $0.05 per share | 9.99 | 1,189,632 | 06/30/2025 Filed 2025-08-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0000950170-25-107640 Dispute this row |
| North Run Advisors, LLC Common Stock, par value $0.05 per share | 9.99 | 1,189,632 | 06/30/2025 Filed 2025-08-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0000950170-25-107640 Dispute this row |
| Todd B. Hammer Common Stock, par value $0.05 per share | 9.99 | 1,189,632 | 06/30/2025 Filed 2025-08-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0000950170-25-107640 Dispute this row |
| Thomas B. Ellis Common Stock, par value $0.05 per share | 9.99 | 1,189,632 | 06/30/2025 Filed 2025-08-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0000950170-25-107640 Dispute this row |
| Michael Bosco Common Stock, par value $0.05 per share | 9.99 | 1,189,632 | 06/30/2025 Filed 2025-08-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0000950170-25-107640 Dispute this row |
| North Run - Due North Partners, LP Common Stock, par value $0.05 per share | 9.99 | 1,189,632 | 06/30/2025 Filed 2025-08-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0000950170-25-107640 Dispute this row |
| North Run GP, LP Common Stock, par value $0.05 per share | 9.99 | 1,189,632 | 06/30/2025 Filed 2025-08-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0000950170-25-107640 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,282,907 filings read, dated 2004-06-14 to 2026-11-17: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 2,524 |
| 2016 | 204,322 |
| 2017 | 203,709 |
| 2018 | 202,770 |
| 2019 | 208,469 |
| 2020 | 144,184 |
| 2021 | 224,474 |
| 2022 | 158,941 |
| 2023 | 199,811 |
| 2024 | 209,823 |
| 2025 | 235,520 |
| 2026 | 260,174 |
Filings made before the SEC required XML are listed, not extracted.